Comparative Pharmacokinetics of HD203, a Biosimilar of Etanercept, with Marketed Etanercept (Enbrel): A Double-Blind, Single-Dose, Crossover Study in Healthy Volunteers

BioDrugs, 05/07/2012

A single subcutaneous injection of HD203 or Enbrel into healthy volunteers appeared to be safe and well tolerated. Comparative pharmacokinetics demonstrated that reconstituted lyophilized HD203 has bioavailability similar to that of Enbrel.

Print Article Summary Cat 2 CME Report